SLC5A2 and heart failure: In terms of treatment, GLP1 and SGLT2 are more commonly prescribed in women and SGLT2 in men, and even more so in people over 75 years of age, possibly because of the higher prevalence of ischaemic heart disease and the relationship between heart failure and age.